The Discounted Cash Flow (DCF) valuation of Amneal Pharmaceuticals Inc (AMRX) is 14.64 USD. With the latest stock price at 10.82 USD, the upside of Amneal Pharmaceuticals Inc based on DCF is 35.3%.
Based on the latest price of 10.82 USD and our DCF valuation, Amneal Pharmaceuticals Inc (AMRX) is a buy. buying Amneal stocks now will result in a potential gain of 35.3%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.4% | 7.9% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 6.77 - 43.60 | 14.64 |
| Upside | -37.4% - 302.9% | 35.3% |